Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation

Dysregulation of tumor-relevant proteins may contribute to human hepatocellular carcinoma (HCC) tumorigenesis. FBXO45 is an E3 ubiquitin ligase that is frequently elevated expression in human HCC. However, it remains unknown whether FBXO45 is associated with hepatocarcinogenesis and how to treat HCC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiao-Tong Lin, Hong-Qiang Yu, Lei Fang, Ye Tan, Ze-Yu Liu, Di Wu, Jie Zhang, Hao-Jun Xiong, Chuan-Ming Xie
Formato: article
Lenguaje:EN
Publicado: eLife Sciences Publications Ltd 2021
Materias:
HCC
R
Q
Acceso en línea:https://doaj.org/article/5535088d5ea945d986f77c586a332b66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5535088d5ea945d986f77c586a332b66
record_format dspace
spelling oai:doaj.org-article:5535088d5ea945d986f77c586a332b662021-12-03T15:55:23ZElevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation10.7554/eLife.707152050-084Xe70715https://doaj.org/article/5535088d5ea945d986f77c586a332b662021-11-01T00:00:00Zhttps://elifesciences.org/articles/70715https://doaj.org/toc/2050-084XDysregulation of tumor-relevant proteins may contribute to human hepatocellular carcinoma (HCC) tumorigenesis. FBXO45 is an E3 ubiquitin ligase that is frequently elevated expression in human HCC. However, it remains unknown whether FBXO45 is associated with hepatocarcinogenesis and how to treat HCC patients with high FBXO45 expression. Here, IHC and qPCR analysis revealed that FBXO45 protein and mRNA were highly expressed in 54.3% (57 of 105) and 52.2% (132 of 253) of the HCC tissue samples, respectively. Highly expressed FBXO45 promoted liver tumorigenesis in transgenic mice. Mechanistically, FBXO45 promoted IGF2BP1 ubiquitination at the Lys190 and Lys450 sites and subsequent activation, leading to the upregulation of PLK1 expression and the induction of cell proliferation and liver tumorigenesis in vitro and in vivo. PLK1 inhibition or IGF2BP1 knockdown significantly blocked FBXO45-driven liver tumorigenesis in FBXO45 transgenic mice, primary cells, and HCCs. Furthermore, IHC analysis on HCC tissue samples revealed a positive association between the hyperexpression of FBXO45 and PLK1/IGF2BP1, and both had positive relationship with poor survival in HCC patients. Thus, FBXO45 plays an important role in promoting liver tumorigenesis through IGF2BP1 ubiquitination and activation, and subsequent PLK1 upregulation, suggesting a new strategy for treating HCC by targeting FBXO45/IGF2BP1/PLK1 axis.Xiao-Tong LinHong-Qiang YuLei FangYe TanZe-Yu LiuDi WuJie ZhangHao-Jun XiongChuan-Ming XieeLife Sciences Publications LtdarticleubiquitinationHCCtumorigenesisFBXO45PLK1IGF2BP1MedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic ubiquitination
HCC
tumorigenesis
FBXO45
PLK1
IGF2BP1
Medicine
R
Science
Q
Biology (General)
QH301-705.5
spellingShingle ubiquitination
HCC
tumorigenesis
FBXO45
PLK1
IGF2BP1
Medicine
R
Science
Q
Biology (General)
QH301-705.5
Xiao-Tong Lin
Hong-Qiang Yu
Lei Fang
Ye Tan
Ze-Yu Liu
Di Wu
Jie Zhang
Hao-Jun Xiong
Chuan-Ming Xie
Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
description Dysregulation of tumor-relevant proteins may contribute to human hepatocellular carcinoma (HCC) tumorigenesis. FBXO45 is an E3 ubiquitin ligase that is frequently elevated expression in human HCC. However, it remains unknown whether FBXO45 is associated with hepatocarcinogenesis and how to treat HCC patients with high FBXO45 expression. Here, IHC and qPCR analysis revealed that FBXO45 protein and mRNA were highly expressed in 54.3% (57 of 105) and 52.2% (132 of 253) of the HCC tissue samples, respectively. Highly expressed FBXO45 promoted liver tumorigenesis in transgenic mice. Mechanistically, FBXO45 promoted IGF2BP1 ubiquitination at the Lys190 and Lys450 sites and subsequent activation, leading to the upregulation of PLK1 expression and the induction of cell proliferation and liver tumorigenesis in vitro and in vivo. PLK1 inhibition or IGF2BP1 knockdown significantly blocked FBXO45-driven liver tumorigenesis in FBXO45 transgenic mice, primary cells, and HCCs. Furthermore, IHC analysis on HCC tissue samples revealed a positive association between the hyperexpression of FBXO45 and PLK1/IGF2BP1, and both had positive relationship with poor survival in HCC patients. Thus, FBXO45 plays an important role in promoting liver tumorigenesis through IGF2BP1 ubiquitination and activation, and subsequent PLK1 upregulation, suggesting a new strategy for treating HCC by targeting FBXO45/IGF2BP1/PLK1 axis.
format article
author Xiao-Tong Lin
Hong-Qiang Yu
Lei Fang
Ye Tan
Ze-Yu Liu
Di Wu
Jie Zhang
Hao-Jun Xiong
Chuan-Ming Xie
author_facet Xiao-Tong Lin
Hong-Qiang Yu
Lei Fang
Ye Tan
Ze-Yu Liu
Di Wu
Jie Zhang
Hao-Jun Xiong
Chuan-Ming Xie
author_sort Xiao-Tong Lin
title Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
title_short Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
title_full Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
title_fullStr Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
title_full_unstemmed Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
title_sort elevated fbxo45 promotes liver tumorigenesis through enhancing igf2bp1 ubiquitination and subsequent plk1 upregulation
publisher eLife Sciences Publications Ltd
publishDate 2021
url https://doaj.org/article/5535088d5ea945d986f77c586a332b66
work_keys_str_mv AT xiaotonglin elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT hongqiangyu elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT leifang elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT yetan elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT zeyuliu elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT diwu elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT jiezhang elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT haojunxiong elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
AT chuanmingxie elevatedfbxo45promoteslivertumorigenesisthroughenhancingigf2bp1ubiquitinationandsubsequentplk1upregulation
_version_ 1718373145906249728